PSTV Past Earnings image   This PSTV past earnings page last updated 7/25/2022
PSTV Past Earnings
PeriodPast Earnings DateGAAP
Q2 20227/21/2022-0.240
Q1 20224/21/2022-0.190
Q4 20212/24/2022-0.270
Q3 202110/21/2021-0.280
Q2 20217/22/2021-0.250
Q1 20214/22/2021-0.330
Q4 20202/22/2021-0.740
Q3 202010/22/2020-0.390
Q2 20208/10/2020-0.450
Q1 20205/14/2020-0.280
Q4 20193/30/20200.660
Q3 201911/14/2019-0.030
Q2 20198/15/2019-5.120
Q1 20195/14/2019-0.180
Q4 20183/29/20190.11
Q3 201811/14/2018-0.45
Q2 20188/14/2018-0.59
Q1 20185/10/2018-0.07
Q4 20173/8/2018-0.1
Q3 201711/9/2017-0.14
Q2 20178/10/2017-0.19
Q1 20175/11/2017-0.26
Q4 20163/23/2017-0.24
Q3 201611/9/2016-0.26
Q2 20168/4/2016-0.43
Q1 20165/10/2016-0.03
Q4 20153/3/2016-0.03
Q3 201511/5/2015-0.04
Q2 20158/6/2015-0.06
Q1 20155/11/2015-0.07
Q4 20143/12/2015-0.08
Q3 201411/6/2014-0.12
Q2 20148/11/2014-0.15
Q1 20145/12/2014-0.14
Q4 20133/11/2014-0.14
Q3 201311/7/2013-0.08
Q2 20138/8/20130.05
Q1 20135/9/2013-0.11
Q4 20123/7/2013-0.55
Q3 201211/8/2012-0.19
Q2 20128/8/2012-0.13
PSTV Past Revenue
PeriodPast Earnings DateGAAP
Q2 20227/21/2022NA
Q1 20224/21/2022NA
Q4 20212/24/2022NA
Q3 202110/21/2021NA
Q2 20217/22/2021NA
Q1 20214/22/2021NA
Q4 20202/22/2021NA
Q3 202010/22/2020NA
Q2 20208/10/20200.00B
Q1 20205/14/20200.00B
Q4 20193/30/20200.00B
Q3 201911/14/20190.00B
Q2 20198/15/20190.00B
Q1 20195/14/20190.00B
Q4 20183/29/20190.00B
Q3 201811/14/20180.00B
Q2 20188/14/20180.00B
Q1 20185/10/20180.00B
Q4 20173/8/20180.00B
Q3 201711/9/20170.00B
Q2 20178/10/20170.00B
Q1 20175/11/20170.00B
Q4 20163/23/20170.00B
Q3 201611/9/20160.00B
Q2 20168/4/20160.00B
Q1 20165/10/20160.00B
Q4 20153/3/20160.00B
Q3 201511/5/20150.00B
Q2 20158/6/20150.00B
Q1 20155/11/20150.00B
Q4 20143/12/20150.00B
Q3 201411/6/20140.00B
Q2 20148/11/20140.00B
Q1 20145/12/20140.00B
Q4 20133/11/20140.00B
Q3 201311/7/20130.00B
Q2 20138/8/20130.00B
Q1 20135/9/20130.00B
Q4 20123/7/20130.01B
Q3 201211/8/20120.00B
Q2 20128/8/20120.00B
Quotes delayed 20 minutes

Email EnvelopeFree PSTV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Plus Therapeutics (PSTV) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PSTX Past Earnings
PTCT Past Earnings
PTE Past Earnings
PTGX Past Earnings
PTIX Past Earnings
PTPI Past Earnings
PULM Past Earnings
QDEL Past Earnings
QLGN Past Earnings
QTRX Past Earnings

PSTV Past Earnings Q&A

What was the best and worst PSTV past earnings results?
For Plus Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PSTV past earnings result in our data set was 0.660/share posted in Q4 2019, while the lowest was in Q2 2019 when PSTV posted -5.120/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2012 when PSTV reported 0.01B in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 41 PSTV past earnings results in our data set.

On this page we presented the PSTV past earnings date information for Plus Therapeutics. Reviewing that PSTV Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2019, when PSTV posted gaap of 0.660/share. Meanwhile the lowest PSTV past earnings result was in Q2 2019, when PSTV posted gaap of -5.120/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2012 when PSTV reported 0.01B in revenue, while the smallest revenue quarter was Q2 2022 when PSTV reported NA in revenue.

Any self directed investor doing their due diligence on PSTV or any other given stock can benefit from researching all of the Plus Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Plus Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PSTV. Thanks for visiting, and the next time you need to research PSTV past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: WPF Videos, ESI Historical Stock Prices, Funds Holding BCRX.

 

PSTV Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.